Literature DB >> 21348872

Defective nuclear factor-κB-inducing kinase in aly/aly mice prevents bone resorption induced by local injection of lipopolysaccharide.

N S Soysa1, N Alles, M Takahashi, K Aoki, K Ohya.   

Abstract

BACKGROUND AND
OBJECTIVE: Nuclear factor-κB (NF-κB) is activated at sites of inflammation in many diseases, including periodontitis. Nuclear factor-κB induces the transcription of proinflammatory cytokines, resulting in increased osteoclastogenesis and bone resorption. Recently, it has been shown that the NF-κB alternative pathway is important for maintainance of physiological bone homeostasis. Activation of this pathway is by processing of the inhibitor p100 into the active subunit p52 by nuclear factor-κB-inducing kinase (NIK). Defective NIK in aly/aly mice (NIK(aly)) causes mild osteopetrosis and blunted RANKL-stimulated osteoclastogenesis in vivo and in vitro, suggesting that NIK is necessary for basal and stimulated osteoclastogenesis. Nevertheless, the role of NIK in pathological bone resorption is not well investigated. The present study was undertaken to investigate the role of NIK in lipopolysaccharide (LPS)-induced inflammatory bone resorption using aly/aly mice.
MATERIAL AND METHODS: Mice were injected with LPS over the calvariae and killed 5 d later. Calvariae were subjected to radiological analysis. Histological sections were stained for tartrate-resistant acid phosphatase, and histomorphometric analysis was performed to quantify the number of osteoclasts and the area of bone resorption.
RESULTS: Lipopolysaccharide-induced inflammation was observed in wild-type and aly/+ mice but not in aly/aly mice. Lipopolysaccharide significantly reduced the calvarial bone mineral density in wild-type and aly/+ mice, whereas bone mineral density was comparable in LPS- and vehicle-injected aly/aly mice. In addition, aly/aly mice were resistant to LPS-induced bone resorption and osteoclastogenesis.
CONCLUSION: Taken together, these data show that NIK is important in the bone-destructive components of inflammation and represents a possible therapeutic target.
© 2010 John Wiley & Sons A/S.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21348872     DOI: 10.1111/j.1600-0765.2010.01333.x

Source DB:  PubMed          Journal:  J Periodontal Res        ISSN: 0022-3484            Impact factor:   4.419


  6 in total

Review 1.  Pathways for bone loss in inflammatory disease.

Authors:  Tobias Braun; Georg Schett
Journal:  Curr Osteoporos Rep       Date:  2012-06       Impact factor: 5.096

2.  NLRP12 provides a critical checkpoint for osteoclast differentiation.

Authors:  Jennifer L Krauss; Rong Zeng; Cynthia L Hickman-Brecks; Justin E Wilson; Jenny P-Y Ting; Deborah V Novack
Journal:  Proc Natl Acad Sci U S A       Date:  2015-08-03       Impact factor: 11.205

Review 3.  NF-κB signaling and bone resorption.

Authors:  Y Abu-Amer
Journal:  Osteoporos Int       Date:  2013-03-07       Impact factor: 4.507

4.  Bergapten prevents lipopolysaccharide mediated osteoclast formation, bone resorption and osteoclast survival.

Authors:  Mingxia Zheng; Yongliang Ge; Haiyu Li; Ming Yan; Jin Zhou; Yun Zhang
Journal:  Int Orthop       Date:  2013-12-04       Impact factor: 3.075

Review 5.  Positive and negative regulators of osteoclast apoptosis.

Authors:  Niroshani Surangika Soysa; Neil Alles
Journal:  Bone Rep       Date:  2019-10-21

6.  Characterization of NLRP12 during the in vivo host immune response to Klebsiella pneumoniae and Mycobacterium tuberculosis.

Authors:  Irving C Allen; Erin McElvania-TeKippe; Justin E Wilson; John D Lich; Janelle C Arthur; Jonathan T Sullivan; Miriam Braunstein; Jenny P Y Ting
Journal:  PLoS One       Date:  2013-04-05       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.